Equatorial Guinea

Reimbursed Care Access

Equatorial Guinea has no public, regulated medical framework for psychedelic-assisted therapies and enforces strict national drug control laws; most classical psychedelics (psilocybin, MDMA, DMT, mescaline, 2C-X, 5‑MeO‑DMT, ibogaine, ayahuasca) are treated as controlled/illegal with no routine medical or reimbursed access outside of authorised research. Ketamine is recognized as an essential anaesthetic agent by WHO and is used in clinical settings as an anaesthetic in low-resource health systems, but there is no publicly documented, reimbursed national program for psychedelic mental‑health indications (e.g., for depression) or for esketamine. National information on specific scheduling texts and implementation is limited in open sources; therefore most psychedelic compounds should be assumed to be criminalised outside tightly controlled medical or research contexts. [https://medlistapp.paho.org/en/list/11|WHO Model List of Essential Medicines (ketamine listing)]